BNC Share Price

Open 21.61 Change Price %
High 21.61 1 Day 0.00 0.00
Low 21.61 1 Week -0.06 -0.28
Close 21.61 1 Month 0.21 0.98
Volume 100 1 Year 21.40 10190.48
52 Week High 23.18
52 Week Low 20.15
BNC Important Levels
Resistance 2 21.61
Resistance 1 21.61
Pivot 21.61
Support 1 21.61
Support 2 21.61
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
CVE 9.55 4.37%
CVE 9.55 4.37%
CVE 9.55 4.37%
SC 60.83 -0.44%
More..
TSE Canada Top Gainers Stocks
CAL 8.00 384.85%
CAL 8.00 384.85%
CAL 8.00 384.85%
TVI 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
PWC 0.10 25.00%
PWC 0.10 25.00%
AAB 0.14 16.67%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
BNG 0.10 -9.09%
BNG 0.10 -9.09%
HCG 16.22 -8.57%
HCG 16.22 -8.57%
HCG 16.22 -8.57%
HCG 16.22 -8.57%
DEJ 0.14 -6.67%
DEJ 0.14 -6.67%
More..

Bioniche Life Sciences Inc (TSE: BNC)

BNC Technical Analysis 5
As on 22nd Jun 2017 BNC Share Price closed @ 21.61 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.05 & Strong Buy for SHORT-TERM with Stoploss of 16.39 we also expect STOCK to react on Following IMPORTANT LEVELS.
BNC Target for June
1st Target up-side 21.93
2nd Target up-side 22.3
3rd Target up-side 22.67
1st Target down-side 20.87
2nd Target down-side 20.5
3rd Target down-side 20.13
BNC Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.bioniche.com
BNC Address
BNC
231 Dundas Street East
Belleville, ON K8N 1E2
Canada
Phone: 613-966-8058
Fax: 613-966-4177
BNC Latest News
Purpose Investments Inc. Announces June Distributions   SYS-CON Media (press release)   - 22nd Jun 17
The market share battle between ETFs and mutual funds heating up as Canadian ...   Financial Post   - 20th Jun 17
There's more to the RRSP than mutual funds and ETFs, but you have to tread ...   Financial Post   - 20th Jun 17
Purpose Investments Inc. Announces May Distributions   Marketwired (press release)   - 20th May 17
The MoneyShow Toronto   Moneyshow.com (registration)   - 23rd Feb 17
BlackRock(R) Canada Announces February Cash Distributions for the iShares(R) ETFs   MarketWatch   - 09th Feb 17
Yield matters so here's a primer on high-dividend-paying stock, bond and ETF ...   Financial Post   - 08th Feb 17
3 Bulletproof ETFs For Income In 2017   Forbes   - 01st Feb 17
Is my ETF's yield too good to be true?   The Globe and Mail   - 15th Oct 16
Investors hungry for returns are piling in Canada long-bond ETFs at a record pace   Financial Post   - 18th Jul 16
Interactive Technical Analysis Chart Bioniche Life Sciences Inc ( BNC TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Bioniche Life Sciences Inc
BNC Business Profile
Bioniche Life Sciences Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, manufacture, and marketing of proprietary products for the human health markets. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which is in Phase III clinical development. The company was formerly known as Vetrepharm Animal Health Inc. Bioniche Life Sciences Inc. was founded in 1979 and is headquartered in Belleville, Canada.